Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 142

Related Articles by Review for PubMed (Select 18519847)

1.

Circulating endothelial progenitor cells in patients with Eisenmenger syndrome and idiopathic pulmonary arterial hypertension.

Diller GP, van Eijl S, Okonko DO, Howard LS, Ali O, Thum T, Wort SJ, Bédard E, Gibbs JS, Bauersachs J, Hobbs AJ, Wilkins MR, Gatzoulis MA, Wharton J.

Circulation. 2008 Jun 10;117(23):3020-30. doi: 10.1161/CIRCULATIONAHA.108.769646. Epub 2008 Jun 2.

2.

Eisenmenger syndrome a clinical perspective in a new therapeutic era of pulmonary arterial hypertension.

Beghetti M, Galiè N.

J Am Coll Cardiol. 2009 Mar 3;53(9):733-40. doi: 10.1016/j.jacc.2008.11.025. Review.

3.

Sildenafil: a review of its use in pulmonary arterial hypertension.

Croom KF, Curran MP.

Drugs. 2008;68(3):383-97. Review.

PMID:
18257613
4.

Management of pulmonary arterial hypertension associated with congenital systemic-to-pulmonary shunts and Eisenmenger's syndrome.

Galie N, Manes A, Palazzini M, Negro L, Marinelli A, Gambetti S, Mariucci E, Donti A, Branzi A, Picchio FM.

Drugs. 2008;68(8):1049-66. Review.

PMID:
18484798
5.

Endothelial progenitor cells in pulmonary arterial hypertension.

Diller GP, Thum T, Wilkins MR, Wharton J.

Trends Cardiovasc Med. 2010 Jan;20(1):22-9. doi: 10.1016/j.tcm.2010.03.003. Review.

PMID:
20685574
6.

Endothelial progenitor cells in angiogenesis.

Xu QB.

Sheng Li Xue Bao. 2005 Feb 25;57(1):1-6. Review.

7.

The involvement of endothelial progenitor cells in tumor angiogenesis.

Ribatti D.

J Cell Mol Med. 2004 Jul-Sep;8(3):294-300. Review.

PMID:
15491505
8.
9.
10.

Endothelial progenitor cells: mobilization, differentiation, and homing.

Hristov M, Erl W, Weber PC.

Arterioscler Thromb Vasc Biol. 2003 Jul 1;23(7):1185-9. Epub 2003 Apr 24. Review.

11.

The nitric oxide/cGMP signaling pathway in pulmonary hypertension.

Klinger JR.

Clin Chest Med. 2007 Mar;28(1):143-67, ix. Review.

PMID:
17338933
12.

[Phosphodiesterase type 5 inhibitors in the treatment of pulmonary arterial hypertension].

Kiliçkesmez K, Küçükoğlu MS.

Anadolu Kardiyol Derg. 2010 Sep;10 Suppl 2:16-8. doi: 10.5152/akd.2010.125. Review. Turkish.

13.

The NO - K+ channel axis in pulmonary arterial hypertension. Activation by experimental oral therapies.

Michelakis ED, McMurtry MS, Sonnenberg B, Archer SL.

Adv Exp Med Biol. 2003;543:293-322. Review.

PMID:
14713130
14.

Sildenafil citrate for the treatment of pulmonary hypertension.

Hrometz SL, Shields KM.

Drugs Today (Barc). 2006 Dec;42(12):771-84. Review.

PMID:
17285150
15.

Endothelial progenitor cells: diagnostic and therapeutic considerations.

Liew A, Barry F, O'Brien T.

Bioessays. 2006 Mar;28(3):261-70. Review.

PMID:
16479582
16.

Role of progenitor endothelial cells in cardiovascular disease and upcoming therapies.

Kawamoto A, Asahara T.

Catheter Cardiovasc Interv. 2007 Oct 1;70(4):477-84. Review.

PMID:
17894361
17.

Pharmacological approaches to improve endothelial repair mechanisms.

Besler C, Doerries C, Giannotti G, Lüscher TF, Landmesser U.

Expert Rev Cardiovasc Ther. 2008 Sep;6(8):1071-82. doi: 10.1586/14779072.6.8.1071. Review.

PMID:
18793110
18.

Pulmonary arterial hypertension associated with congenital heart disease.

D'Alto M, Mahadevan VS.

Eur Respir Rev. 2012 Dec 1;21(126):328-37. doi: 10.1183/09059180.00004712. Review.

19.

Role of apoptosis in pulmonary hypertension: from experimental models to clinical trials.

Jurasz P, Courtman D, Babaie S, Stewart DJ.

Pharmacol Ther. 2010 Apr;126(1):1-8. doi: 10.1016/j.pharmthera.2009.12.006. Epub 2010 Feb 1. Review.

PMID:
20117135
20.

Sildenafil for pulmonary arterial hypertension: when blue turns into white.

Antoniu SA.

Expert Opin Pharmacother. 2006 Sep;7(13):1801-10. Review.

PMID:
16925506
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk